Global Lung Cancer Diagnostic And Screening Market Growth (Status and Outlook) 2025-2031

Publication ID:

LPI06254086

Publication Date:

June 20, 2025

Pages:

137

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

IT Services [2]

Software [3]

Computing & Electronics [4]

Description:

The global Lung Cancer Diagnostic And Screening market size is predicted to grow from US$ 85.2 million in 2025 to US$ 113 million in 2031; it is expected to grow at a CAGR of 4.8% from 2025 to 2031.
The Lung Cancer Diagnostic and Screening market is experiencing significant growth and is expected to continue to expand in the coming years. Lung cancer is a major global health concern, and early detection and accurate diagnosis are crucial for improving patient outcomes.One major trend in the Lung Cancer Diagnostic and Screening market is the increasing adoption of advanced imaging technologies for lung cancer detection. Technologies such as computed tomography (CT) scans and positron emission tomography (PET) scans are widely used for screening and diagnosing lung cancer. These imaging techniques provide detailed images of the lungs, allowing healthcare professionals to detect lung nodules or tumors at an early stage.
The 鈥淟ung Cancer Diagnostic And Screening Industry Forecast鈥� looks at past sales and reviews total world Lung Cancer Diagnostic And Screening sales in 2024, providing a comprehensive analysis by region and market sector of projected Lung Cancer Diagnostic And Screening sales for 2025 through 2031. With Lung Cancer Diagnostic And Screening sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Lung Cancer Diagnostic And Screening industry.
This Insight Report provides a comprehensive analysis of the global Lung Cancer Diagnostic And Screening landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Lung Cancer Diagnostic And Screening portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Lung Cancer Diagnostic And Screening market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Lung Cancer Diagnostic And Screening and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Lung Cancer Diagnostic And Screening.
This report presents a comprehensive overview, market shares, and growth opportunities of Lung Cancer Diagnostic And Screening market by product type, application, key players and key regions and countries.
Segmentation by Type:
Instrument
Consumables and Accessories
Segmentation by Application:
Hospital
Independent Diagnostic Laboratory
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Pfizer
F.Hoffmann-La Roche AG
Bristol-Myers Squibb Company
Thermo Fisher Scientific
AstraZeneca Plc
Abbott Laboratories
Medtronic Plc
Danaher Corporation
Siemens Healthcare GmbH
FUJIFILM Corporation
KoninklijikePhilips N.V.
GE Healthcare Bio Sciences AB
Quest Diagnostics lIncorporated
Agilent Technologies lnc
Qiagen Inc.
Myriad Genetic Laboratories Inc.
NeoGenomics Laboratories Inc
Canon MedicalSystems Corporation
Eon Health Inc

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Lung Cancer Diagnostic And Screening Market Size (2020-2031)
2.1.2 Lung Cancer Diagnostic And Screening Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Lung Cancer Diagnostic And Screening by Country/Region (2020, 2024 & 2031)
2.2 Lung Cancer Diagnostic And Screening Segment by Type
2.2.1 Instrument
2.2.2 Consumables and Accessories
2.3 Lung Cancer Diagnostic And Screening Market Size by Type
2.3.1 Lung Cancer Diagnostic And Screening Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Lung Cancer Diagnostic And Screening Market Size Market Share by Type (2020-2025)
2.4 Lung Cancer Diagnostic And Screening Segment by Application
2.4.1 Hospital
2.4.2 Independent Diagnostic Laboratory
2.5 Lung Cancer Diagnostic And Screening Market Size by Application
2.5.1 Lung Cancer Diagnostic And Screening Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Lung Cancer Diagnostic And Screening Market Size Market Share by Application (2020-2025)
3 Lung Cancer Diagnostic And Screening Market Size by Player
3.1 Lung Cancer Diagnostic And Screening Market Size Market Share by Player
3.1.1 Global Lung Cancer Diagnostic And Screening Revenue by Player (2020-2025)
3.1.2 Global Lung Cancer Diagnostic And Screening Revenue Market Share by Player (2020-2025)
3.2 Global Lung Cancer Diagnostic And Screening Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Lung Cancer Diagnostic And Screening by Region
4.1 Lung Cancer Diagnostic And Screening Market Size by Region (2020-2025)
4.2 Global Lung Cancer Diagnostic And Screening Annual Revenue by Country/Region (2020-2025)
4.3 Americas Lung Cancer Diagnostic And Screening Market Size Growth (2020-2025)
4.4 APAC Lung Cancer Diagnostic And Screening Market Size Growth (2020-2025)
4.5 Europe Lung Cancer Diagnostic And Screening Market Size Growth (2020-2025)
4.6 Middle East & Africa Lung Cancer Diagnostic And Screening Market Size Growth (2020-2025)
5 Americas
5.1 Americas Lung Cancer Diagnostic And Screening Market Size by Country (2020-2025)
5.2 Americas Lung Cancer Diagnostic And Screening Market Size by Type (2020-2025)
5.3 Americas Lung Cancer Diagnostic And Screening Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Lung Cancer Diagnostic And Screening Market Size by Region (2020-2025)
6.2 APAC Lung Cancer Diagnostic And Screening Market Size by Type (2020-2025)
6.3 APAC Lung Cancer Diagnostic And Screening Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Lung Cancer Diagnostic And Screening Market Size by Country (2020-2025)
7.2 Europe Lung Cancer Diagnostic And Screening Market Size by Type (2020-2025)
7.3 Europe Lung Cancer Diagnostic And Screening Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Lung Cancer Diagnostic And Screening by Region (2020-2025)
8.2 Middle East & Africa Lung Cancer Diagnostic And Screening Market Size by Type (2020-2025)
8.3 Middle East & Africa Lung Cancer Diagnostic And Screening Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Lung Cancer Diagnostic And Screening Market Forecast
10.1 Global Lung Cancer Diagnostic And Screening Forecast by Region (2026-2031)
10.1.1 Global Lung Cancer Diagnostic And Screening Forecast by Region (2026-2031)
10.1.2 Americas Lung Cancer Diagnostic And Screening Forecast
10.1.3 APAC Lung Cancer Diagnostic And Screening Forecast
10.1.4 Europe Lung Cancer Diagnostic And Screening Forecast
10.1.5 Middle East & Africa Lung Cancer Diagnostic And Screening Forecast
10.2 Americas Lung Cancer Diagnostic And Screening Forecast by Country (2026-2031)
10.2.1 United States Market Lung Cancer Diagnostic And Screening Forecast
10.2.2 Canada Market Lung Cancer Diagnostic And Screening Forecast
10.2.3 Mexico Market Lung Cancer Diagnostic And Screening Forecast
10.2.4 Brazil Market Lung Cancer Diagnostic And Screening Forecast
10.3 APAC Lung Cancer Diagnostic And Screening Forecast by Region (2026-2031)
10.3.1 China Lung Cancer Diagnostic And Screening Market Forecast
10.3.2 Japan Market Lung Cancer Diagnostic And Screening Forecast
10.3.3 Korea Market Lung Cancer Diagnostic And Screening Forecast
10.3.4 Southeast Asia Market Lung Cancer Diagnostic And Screening Forecast
10.3.5 India Market Lung Cancer Diagnostic And Screening Forecast
10.3.6 Australia Market Lung Cancer Diagnostic And Screening Forecast
10.4 Europe Lung Cancer Diagnostic And Screening Forecast by Country (2026-2031)
10.4.1 Germany Market Lung Cancer Diagnostic And Screening Forecast
10.4.2 France Market Lung Cancer Diagnostic And Screening Forecast
10.4.3 UK Market Lung Cancer Diagnostic And Screening Forecast
10.4.4 Italy Market Lung Cancer Diagnostic And Screening Forecast
10.4.5 Russia Market Lung Cancer Diagnostic And Screening Forecast
10.5 Middle East & Africa Lung Cancer Diagnostic And Screening Forecast by Region (2026-2031)
10.5.1 Egypt Market Lung Cancer Diagnostic And Screening Forecast
10.5.2 South Africa Market Lung Cancer Diagnostic And Screening Forecast
10.5.3 Israel Market Lung Cancer Diagnostic And Screening Forecast
10.5.4 Turkey Market Lung Cancer Diagnostic And Screening Forecast
10.6 Global Lung Cancer Diagnostic And Screening Forecast by Type (2026-2031)
10.7 Global Lung Cancer Diagnostic And Screening Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Lung Cancer Diagnostic And Screening Forecast
11 Key Players Analysis
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer Lung Cancer Diagnostic And Screening Product Offered
11.1.3 Pfizer Lung Cancer Diagnostic And Screening Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Pfizer Main Business Overview
11.1.5 Pfizer Latest Developments
11.2 F.Hoffmann-La Roche AG
11.2.1 F.Hoffmann-La Roche AG Company Information
11.2.2 F.Hoffmann-La Roche AG Lung Cancer Diagnostic And Screening Product Offered
11.2.3 F.Hoffmann-La Roche AG Lung Cancer Diagnostic And Screening Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 F.Hoffmann-La Roche AG Main Business Overview
11.2.5 F.Hoffmann-La Roche AG Latest Developments
11.3 Bristol-Myers Squibb Company
11.3.1 Bristol-Myers Squibb Company Company Information
11.3.2 Bristol-Myers Squibb Company Lung Cancer Diagnostic And Screening Product Offered
11.3.3 Bristol-Myers Squibb Company Lung Cancer Diagnostic And Screening Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Bristol-Myers Squibb Company Main Business Overview
11.3.5 Bristol-Myers Squibb Company Latest Developments
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Information
11.4.2 Thermo Fisher Scientific Lung Cancer Diagnostic And Screening Product Offered
11.4.3 Thermo Fisher Scientific Lung Cancer Diagnostic And Screening Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Thermo Fisher Scientific Main Business Overview
11.4.5 Thermo Fisher Scientific Latest Developments
11.5 AstraZeneca Plc
11.5.1 AstraZeneca Plc Company Information
11.5.2 AstraZeneca Plc Lung Cancer Diagnostic And Screening Product Offered
11.5.3 AstraZeneca Plc Lung Cancer Diagnostic And Screening Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 AstraZeneca Plc Main Business Overview
11.5.5 AstraZeneca Plc Latest Developments
11.6 Abbott Laboratories
11.6.1 Abbott Laboratories Company Information
11.6.2 Abbott Laboratories Lung Cancer Diagnostic And Screening Product Offered
11.6.3 Abbott Laboratories Lung Cancer Diagnostic And Screening Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Abbott Laboratories Main Business Overview
11.6.5 Abbott Laboratories Latest Developments
11.7 Medtronic Plc
11.7.1 Medtronic Plc Company Information
11.7.2 Medtronic Plc Lung Cancer Diagnostic And Screening Product Offered
11.7.3 Medtronic Plc Lung Cancer Diagnostic And Screening Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Medtronic Plc Main Business Overview
11.7.5 Medtronic Plc Latest Developments
11.8 Danaher Corporation
11.8.1 Danaher Corporation Company Information
11.8.2 Danaher Corporation Lung Cancer Diagnostic And Screening Product Offered
11.8.3 Danaher Corporation Lung Cancer Diagnostic And Screening Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Danaher Corporation Main Business Overview
11.8.5 Danaher Corporation Latest Developments
11.9 Siemens Healthcare GmbH
11.9.1 Siemens Healthcare GmbH Company Information
11.9.2 Siemens Healthcare GmbH Lung Cancer Diagnostic And Screening Product Offered
11.9.3 Siemens Healthcare GmbH Lung Cancer Diagnostic And Screening Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Siemens Healthcare GmbH Main Business Overview
11.9.5 Siemens Healthcare GmbH Latest Developments
11.10 FUJIFILM Corporation
11.10.1 FUJIFILM Corporation Company Information
11.10.2 FUJIFILM Corporation Lung Cancer Diagnostic And Screening Product Offered
11.10.3 FUJIFILM Corporation Lung Cancer Diagnostic And Screening Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 FUJIFILM Corporation Main Business Overview
11.10.5 FUJIFILM Corporation Latest Developments
11.11 KoninklijikePhilips N.V.
11.11.1 KoninklijikePhilips N.V. Company Information
11.11.2 KoninklijikePhilips N.V. Lung Cancer Diagnostic And Screening Product Offered
11.11.3 KoninklijikePhilips N.V. Lung Cancer Diagnostic And Screening Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 KoninklijikePhilips N.V. Main Business Overview
11.11.5 KoninklijikePhilips N.V. Latest Developments
11.12 GE Healthcare Bio Sciences AB
11.12.1 GE Healthcare Bio Sciences AB Company Information
11.12.2 GE Healthcare Bio Sciences AB Lung Cancer Diagnostic And Screening Product Offered
11.12.3 GE Healthcare Bio Sciences AB Lung Cancer Diagnostic And Screening Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 GE Healthcare Bio Sciences AB Main Business Overview
11.12.5 GE Healthcare Bio Sciences AB Latest Developments
11.13 Quest Diagnostics lIncorporated
11.13.1 Quest Diagnostics lIncorporated Company Information
11.13.2 Quest Diagnostics lIncorporated Lung Cancer Diagnostic And Screening Product Offered
11.13.3 Quest Diagnostics lIncorporated Lung Cancer Diagnostic And Screening Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Quest Diagnostics lIncorporated Main Business Overview
11.13.5 Quest Diagnostics lIncorporated Latest Developments
11.14 Agilent Technologies lnc
11.14.1 Agilent Technologies lnc Company Information
11.14.2 Agilent Technologies lnc Lung Cancer Diagnostic And Screening Product Offered
11.14.3 Agilent Technologies lnc Lung Cancer Diagnostic And Screening Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Agilent Technologies lnc Main Business Overview
11.14.5 Agilent Technologies lnc Latest Developments
11.15 Qiagen Inc.
11.15.1 Qiagen Inc. Company Information
11.15.2 Qiagen Inc. Lung Cancer Diagnostic And Screening Product Offered
11.15.3 Qiagen Inc. Lung Cancer Diagnostic And Screening Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 Qiagen Inc. Main Business Overview
11.15.5 Qiagen Inc. Latest Developments
11.16 Myriad Genetic Laboratories Inc.
11.16.1 Myriad Genetic Laboratories Inc. Company Information
11.16.2 Myriad Genetic Laboratories Inc. Lung Cancer Diagnostic And Screening Product Offered
11.16.3 Myriad Genetic Laboratories Inc. Lung Cancer Diagnostic And Screening Revenue, Gross Margin and Market Share (2020-2025)
11.16.4 Myriad Genetic Laboratories Inc. Main Business Overview
11.16.5 Myriad Genetic Laboratories Inc. Latest Developments
11.17 NeoGenomics Laboratories Inc
11.17.1 NeoGenomics Laboratories Inc Company Information
11.17.2 NeoGenomics Laboratories Inc Lung Cancer Diagnostic And Screening Product Offered
11.17.3 NeoGenomics Laboratories Inc Lung Cancer Diagnostic And Screening Revenue, Gross Margin and Market Share (2020-2025)
11.17.4 NeoGenomics Laboratories Inc Main Business Overview
11.17.5 NeoGenomics Laboratories Inc Latest Developments
11.18 Canon MedicalSystems Corporation
11.18.1 Canon MedicalSystems Corporation Company Information
11.18.2 Canon MedicalSystems Corporation Lung Cancer Diagnostic And Screening Product Offered
11.18.3 Canon MedicalSystems Corporation Lung Cancer Diagnostic And Screening Revenue, Gross Margin and Market Share (2020-2025)
11.18.4 Canon MedicalSystems Corporation Main Business Overview
11.18.5 Canon MedicalSystems Corporation Latest Developments
11.19 Eon Health Inc
11.19.1 Eon Health Inc Company Information
11.19.2 Eon Health Inc Lung Cancer Diagnostic And Screening Product Offered
11.19.3 Eon Health Inc Lung Cancer Diagnostic And Screening Revenue, Gross Margin and Market Share (2020-2025)
11.19.4 Eon Health Inc Main Business Overview
11.19.5 Eon Health Inc Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂